ARMC
CELU icon

American Research & Management Company’s Celularity CELU Stock Holding History

American Research & Management Company’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11
Closed – – 427
2022
Q2 		$0 Buy
11
+6
+120% +$487 ﹤0.01% 399
2022
Q1 		$0 Hold
5
– – ﹤0.01% 400
2021
Q4 		$0 Buy
+5
New +$320 ﹤0.01% 388
2021
Q3 		– Sell
-5
Closed -$1K – 380
2021
Q2 		$1K Hold
5
– – ﹤0.01% 367
2021
Q1 		$1K Buy
+5
New +$512 ﹤0.01% 351

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

American Research & Management Company's CELU Position: Q3 2022 in Review

American Research & Management Company sold out of Celularity (CELU) in Q3 2022, closing a stake of 11 shares.

American Research & Management Company first reported a position in CELU in Q1 2021 and held it in 5 quarters. The position peaked at $1K in Q2 2021. 72 funds tracked by Wall St. Rank hold CELU as of Q3 2022.

  • American Research & Management Company reported no remaining Celularity position as of Q3 2022 after selling out during the quarter.
  • American Research & Management Company sold 11 Celularity shares in Q3 2022.
  • American Research & Management Company first reported a position in Celularity in Q1 2021 and held it in 5 quarters.
  • American Research & Management Company's Celularity position peaked at $1K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Celularity as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.